Prestigious International Annual Awards Program Honors Standout AI Companies & Solutions
BostonGene, a leader in AI-powered solutions for drug discovery and development, has been honored with the “AI-based Drug Discovery Solution of the Year” award in the 8th annual AI Breakthrough Awards program. AI Breakthrough is a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market.
BostonGene’s breakthrough AI platform is transforming oncology research and drug development by integrating high throughput tissue analytics with genomic, transcriptomic and clinical data. This multimodal approach creates biological signatures, leading to improved target identification and enhanced patient stratification for clinical trials.
As part of its integrated solution, BostonGene’s novel AI-driven platform combines advanced digital pathology capabilities–such as pixel-level analysis of whole slide images–with molecular and clinical data. The insights that BostonGene’s platform delivers sharpen the precision of predictive biomarker and therapeutic target discovery.
“BostonGene’s AI platform stands out for its ability to synthesize clinical, molecular and imaging data–generating comprehensive, actionable insights that drive drug development and precision oncology,” said Steve Johansson, managing director, AI Breakthrough. “BostonGene’s AI platform delivers powerful, accurate and reproducible biological signatures that represent an enhanced approach drug development – bringing precision oncology closer to clinical reality.”
“Through our strategic collaborations with leading cancer centers and pharmaceutical companies, we are integrating advanced technology like AI into oncology care,” said Ferran Prat, PhD, JD, Chief Commercial Officer at BostonGene. “We’re grateful to AI Breakthrough for the ‘AI-based Drug Discovery Solution of the Year’ award, and we will continue to focus on using innovative AI-powered solutions to revolutionize personalized cancer treatment, expedite drug development and improve patient outcomes.”
The AI Breakthrough Awards shine a spotlight on the boldest innovators and most impactful technologies that are leading the charge in AI across a comprehensive set of categories, including Generative AI, Computer Vision, AIOps, Agentic AI, Robotics, Natural Language Processing, industry-specific AI applications and many more. This year’s program attracted more than 5,000 nominations from over 20 different countries, underscoring the explosive growth and global importance of AI as a defining technology of the 21st century.